Biotech Is Fueling An All-New Cannabis Boom

NEW YORK, Jan. 21, 2021 /PRNewswire/ -- On October 10, 1962, JFK signed into law a little-known act that helped put a massive $1.25 trillion industry on the map. And today, the trillion-dollar pharmaceutical industry is being pushed to make a shift.  Mentioned in today's commentary includes:  AbbVie Inc. (NYSE: ABBV), NewAge, Inc. (NASDAQ: NBEV), The Scotts Miracle-Gro Company (NYSE: SMG), Aphria Inc. (NASDAQ: APHA), The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF).

This is a new way to create safe, proven treatments while saving companies significant amounts of money...Treatments that could help ease common ailments that plague millions of folks each year like chronic pain, inflammation, migraines, and more.

It could have tremendous implications for the future of the biotech market. That's because the 1962 Kefauver Harris Amendment helped make sure the medications we take are both safe and effective...But that often came with long, arduous review processes that left desperate people waiting years for relief. 

In 2020, however, we've seen a massive shift take place in the biotech industry thanks to the fast-tracked COVID vaccine…Proving that with today's technology, it's finally possible to cut through the red tape in the process…Delivering the potential to produce treatments and vaccines that are both safe and effective at record speeds. And now, the next possible breakthrough in health sciences is in the perfect position to capitalize on that in 2021 and the little known company at the forefront is called Juva Life (JUVA; JUVAF).

Many of the companies in this market are seeing incredible gains this year.

Harborside, Inc., a San Francisco-based dispensary operator, saw shares soar 423% in just 9 months. Indus Holdings, another manufacturer and distributor in the Bay Area, launched for extraordinary 528% gains in 2020. But some investors are keeping their eyes on another young company near San Francisco that has big plans in store.

In December, their shares were up an impressive 44% in just three weeks. But with a target to do things differently, they have even greater plans in the months to come.

Juva Life (JUVA; JUVAF) aims to have a large database for evidence-based cannabis treatments…And they'll soon have the facilities to take that valuable data proving what works best and for who…And turn it into an asset that could potentially make them an instant acquisition target.